Literature DB >> 22593122

Coil embolization for treatment of vascular complications after nephron-sparing surgery.

Karsten Krüger1, E Siakavara.   

Abstract

Nephron-sparing surgery (NSS) is a standard surgical treatment for small renal tumors. We report four patients (aged 35-79 years) with vascular complications within 6 days to 3 months after open NSS. Three patients developed acute symptoms, whereas one was asymptomatic. Computed tomography (CT) in the arterial and venous phase of contrast enhancement was performed for diagnosis, followed by angiography. CT demonstrated a perirenal hematoma in three and an arterial pseudoaneurysm in two cases. Unlike CT, digital subtraction angiography confirmed an arterial pseudoaneurysm in all cases and additionally found an arteriovenous fistula in three. In all cases, angiography-guided coil embolization successfully treated the vascular pathology, while preserving renal function. Clinicians should understand the diagnosis and management of this complication of NSS.

Entities:  

Mesh:

Year:  2012        PMID: 22593122     DOI: 10.1258/ar.2012.110432

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  3 in total

1.  [False aneurysm with secondary AV fistula after partial nephrectomy: diagnosis and therapy].

Authors:  S Tietze; J Peruth; J Krause; A Hamza
Journal:  Urologe A       Date:  2014-09       Impact factor: 0.639

2.  Successful Treatment of Iatrogenic External Iliac Artery Perforation With Covered Stent: Case Report and Review of the Literature.

Authors:  Muhammad Umer Awan; Bassam Omar; Ghazanfar Qureshi; Ghulam Mustafa Awan
Journal:  Cardiol Res       Date:  2017-10-27

3.  Emergency management of iatrogenic arterial injuries with a low-profile balloon-expandable stent-graft: Preliminary results.

Authors:  Maria Antonella Ruffino; Marco Fronda; Sara Varello; Andrea Discalzi; Andrea Mancini; Pierluigi Muratore; Denis Rossato; Laura Bergamasco; Dorico Righi; Paolo Fonio
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.